Bevacizumab (Avastin) Plus Oxaliplatin-Based Combination Chemotherapy:Update on Recent Trials

Reviewer: Christopher Dolinsky, MD
University of Pennsylvania School of Medicine
Ultima Vez Modificado: 3 de noviembre del 2005

Translation for this article does not exist